von Angerer E - Search Results

1

Evaluation of the antitumour activity of coumarin in prostate cancer models.

Maucher A, Kager M, von Angerer E. Maucher A, et al. Among authors: von angerer e. J Cancer Res Clin Oncol. 1993;119(3):150-4. doi: 10.1007/BF01229529. J Cancer Res Clin Oncol. 1993. PMID: 8418087

2

[(2-Phenylindol-3-yl)methylene]propanedinitriles inhibit the growth of breast cancer cells by cell cycle arrest in G(2)/M phase and apoptosis.

Pojarová M, Kaufmann D, Gastpar R, Nishino T, Reszka P, Bednarski PJ, von Angerer E. Pojarová M, et al. Among authors: von angerer e. Bioorg Med Chem. 2007 Dec 1;15(23):7368-79. doi: 10.1016/j.bmc.2007.07.046. Epub 2007 Aug 21. Bioorg Med Chem. 2007. PMID: 17889547

3

Antimitotic activities of 2-phenylindole-3-carbaldehydes in human breast cancer cells.

Kaufmann D, Pojarová M, Vogel S, Liebl R, Gastpar R, Gross D, Nishino T, Pfaller T, von Angerer E. Kaufmann D, et al. Among authors: von angerer e. Bioorg Med Chem. 2007 Aug 1;15(15):5122-36. doi: 10.1016/j.bmc.2007.05.030. Epub 2007 May 17. Bioorg Med Chem. 2007. PMID: 17533132

4

Platinum(II) complexes interfering with testicular steroid biosynthesis: drugs for the therapy of advanced or recurrent prostate cancers? Preclinical studies.

Schertl S, Hartmann RW, Batzl-Hartmann C, Spruss T, Maucher A, von Angerer E, Schiller CD, Schneider MR, Gust R, Schönenberger H. Schertl S, et al. Among authors: von angerer e. J Cancer Res Clin Oncol. 2007 Mar;133(3):153-67. doi: 10.1007/s00432-006-0151-3. Epub 2006 Oct 6. J Cancer Res Clin Oncol. 2007. PMID: 17024493

5

Synthesis and biological evaluation of stilbene-based pure estrogen antagonists.

Walter G, Liebl R, von Angerer E. Walter G, et al. Among authors: von angerer e. Bioorg Med Chem Lett. 2004 Sep 20;14(18):4659-63. doi: 10.1016/j.bmcl.2004.06.098. Bioorg Med Chem Lett. 2004. PMID: 15324884

6

Sulfamoyloxy-substituted 2-phenylindoles: antiestrogen-based inhibitors of the steroid sulfatase in human breast cancer cells.

Golob T, Liebl R, von Angerer E. Golob T, et al. Among authors: von angerer e. Bioorg Med Chem. 2002 Dec;10(12):3941-53. doi: 10.1016/s0968-0896(02)00306-1. Bioorg Med Chem. 2002. PMID: 12413846

7

Effect of the nonsteroidal antiestrogen ZK 119.010 on growth and metastasis of the EnDA endometrial carcinoma.

Horn DW, Vollmer G, von Angerer E, Schneider MR. Horn DW, et al. Among authors: von angerer e. Int J Cancer. 1994 Aug 1;58(3):426-9. doi: 10.1002/ijc.2910580320. Int J Cancer. 1994. PMID: 8050824

8

Antitumour activity of coumarin and 7-hydroxycoumarin against 7,12-dimethylbenz[a]anthracene-induced rat mammary carcinomas.

Maucher A, von Angerer E. Maucher A, et al. Among authors: von angerer e. J Cancer Res Clin Oncol. 1994;120(8):502-4. doi: 10.1007/BF01191806. J Cancer Res Clin Oncol. 1994. PMID: 8207051

9

The inhibitory effect of 4-chloro-2-(2,6-dichloro-4-hydroxyphenyl)-1-ethyl-6-hydroxyindole (D 15413) on estrogen-dependent mammary tumors.

von Angerer E, Prekajac J, Schneider MR, Berger MR. von Angerer E, et al. J Cancer Res Clin Oncol. 1985;110(3):216-20. doi: 10.1007/BF00399276. J Cancer Res Clin Oncol. 1985. PMID: 4077919

10

Studies on the mammary tumor-inhibiting effects of diethylstilbestrol and its mono- and diphosphate.

Schneider MR, von Angerer E, Prekajac J, Brade WP. Schneider MR, et al. Among authors: von angerer e. J Cancer Res Clin Oncol. 1986;111(2):110-4. doi: 10.1007/BF00400747. J Cancer Res Clin Oncol. 1986. PMID: 3754557

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results